

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axoneme assembly (GO:0035082) | 8.59079682 |
| 2 | regulation of cilium movement (GO:0003352) | 7.28860004 |
| 3 | left/right pattern formation (GO:0060972) | 5.88200031 |
| 4 | left/right axis specification (GO:0070986) | 5.78572331 |
| 5 | cilium organization (GO:0044782) | 5.70871337 |
| 6 | cilium assembly (GO:0042384) | 5.53208189 |
| 7 | positive regulation of cellular amide metabolic process (GO:0034250) | 5.50105944 |
| 8 | protein localization to cilium (GO:0061512) | 5.23653332 |
| 9 | intraciliary transport (GO:0042073) | 5.07253079 |
| 10 | microtubule bundle formation (GO:0001578) | 4.96963805 |
| 11 | ventricular system development (GO:0021591) | 4.77314005 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.75416423 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.75416423 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 4.75416423 |
| 15 | positive regulation by symbiont of host defense response (GO:0052509) | 4.75416423 |
| 16 | modulation by symbiont of host defense response (GO:0052031) | 4.75416423 |
| 17 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.75416423 |
| 18 | detection of molecule of bacterial origin (GO:0032490) | 4.73782005 |
| 19 | neutrophil activation involved in immune response (GO:0002283) | 4.72717617 |
| 20 | respiratory burst (GO:0045730) | 4.62282760 |
| 21 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.59380224 |
| 22 | cilium morphogenesis (GO:0060271) | 4.51632671 |
| 23 | cellular component assembly involved in morphogenesis (GO:0010927) | 4.42724249 |
| 24 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.32320885 |
| 25 | detection of other organism (GO:0098543) | 4.28141913 |
| 26 | diterpenoid biosynthetic process (GO:0016102) | 4.23216431 |
| 27 | regulation of microtubule-based movement (GO:0060632) | 4.20689815 |
| 28 | neutrophil mediated immunity (GO:0002446) | 4.13569426 |
| 29 | centriole assembly (GO:0098534) | 4.10232494 |
| 30 | positive regulation of mast cell activation (GO:0033005) | 3.98628425 |
| 31 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.94262488 |
| 32 | ether lipid metabolic process (GO:0046485) | 3.92965804 |
| 33 | negative regulation of T cell differentiation in thymus (GO:0033085) | 3.79721523 |
| 34 | tolerance induction (GO:0002507) | 3.78090174 |
| 35 | cell projection assembly (GO:0030031) | 3.77577851 |
| 36 | reactive oxygen species biosynthetic process (GO:1903409) | 3.71786344 |
| 37 | macrophage activation involved in immune response (GO:0002281) | 3.70824704 |
| 38 | alpha-linolenic acid metabolic process (GO:0036109) | 3.70742446 |
| 39 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.70263868 |
| 40 | primary alcohol catabolic process (GO:0034310) | 3.68015569 |
| 41 | detection of external biotic stimulus (GO:0098581) | 3.67590804 |
| 42 | response to host immune response (GO:0052572) | 3.66804002 |
| 43 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.66804002 |
| 44 | negative regulation of B cell mediated immunity (GO:0002713) | 3.65244466 |
| 45 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.65244466 |
| 46 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.63650280 |
| 47 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.62742664 |
| 48 | regulation of growth of symbiont in host (GO:0044126) | 3.62742664 |
| 49 | negative regulation of growth of symbiont in host (GO:0044130) | 3.62742664 |
| 50 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.62742664 |
| 51 | neutrophil activation (GO:0042119) | 3.61314011 |
| 52 | microtubule depolymerization (GO:0007019) | 3.59290030 |
| 53 | microtubule-based movement (GO:0007018) | 3.56665976 |
| 54 | regulation of germinal center formation (GO:0002634) | 3.56618224 |
| 55 | granulocyte activation (GO:0036230) | 3.53693268 |
| 56 | sperm motility (GO:0030317) | 3.53541989 |
| 57 | response to host (GO:0075136) | 3.51041363 |
| 58 | response to host defenses (GO:0052200) | 3.51041363 |
| 59 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.51041363 |
| 60 | vitamin transmembrane transport (GO:0035461) | 3.50310864 |
| 61 | terpenoid biosynthetic process (GO:0016114) | 3.44757869 |
| 62 | nucleoside diphosphate phosphorylation (GO:0006165) | 3.43848395 |
| 63 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.42804042 |
| 64 | exogenous drug catabolic process (GO:0042738) | 3.40371983 |
| 65 | response to peptidoglycan (GO:0032494) | 3.39114617 |
| 66 | fatty acid elongation (GO:0030497) | 3.37943923 |
| 67 | regulation of cellular amide metabolic process (GO:0034248) | 3.34562599 |
| 68 | one-carbon compound transport (GO:0019755) | 3.29539001 |
| 69 | positive regulation of macrophage cytokine production (GO:0060907) | 3.27764476 |
| 70 | negative regulation of humoral immune response (GO:0002921) | 3.27297605 |
| 71 | detection of biotic stimulus (GO:0009595) | 3.26500969 |
| 72 | detection of bacterium (GO:0016045) | 3.24135326 |
| 73 | nonmotile primary cilium assembly (GO:0035058) | 3.21483087 |
| 74 | centriole replication (GO:0007099) | 3.19609304 |
| 75 | determination of left/right symmetry (GO:0007368) | 3.15808797 |
| 76 | complement activation, classical pathway (GO:0006958) | 3.15781660 |
| 77 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.15069184 |
| 78 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.15069184 |
| 79 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.07914277 |
| 80 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.06834086 |
| 81 | myeloid leukocyte mediated immunity (GO:0002444) | 3.04164962 |
| 82 | neural tube formation (GO:0001841) | 3.03537993 |
| 83 | glomerular epithelial cell development (GO:0072310) | 3.03253410 |
| 84 | negative regulation of complement activation (GO:0045916) | 3.01329886 |
| 85 | retinoic acid metabolic process (GO:0042573) | 2.99666083 |
| 86 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.98954203 |
| 87 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.98948633 |
| 88 | positive regulation of mast cell degranulation (GO:0043306) | 2.98948633 |
| 89 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.98590227 |
| 90 | protein neddylation (GO:0045116) | 2.96793111 |
| 91 | positive regulation of tolerance induction (GO:0002645) | 2.96435531 |
| 92 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.96089900 |
| 93 | determination of bilateral symmetry (GO:0009855) | 2.96036414 |
| 94 | behavioral response to nicotine (GO:0035095) | 2.93763828 |
| 95 | retinal rod cell development (GO:0046548) | 2.93121141 |
| 96 | positive regulation of leukocyte degranulation (GO:0043302) | 2.91866879 |
| 97 | apoptotic cell clearance (GO:0043277) | 2.91716111 |
| 98 | drug catabolic process (GO:0042737) | 2.91170260 |
| 99 | photoreceptor cell maintenance (GO:0045494) | 2.91123339 |
| 100 | retinal cone cell development (GO:0046549) | 2.90844763 |
| 101 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.89323483 |
| 102 | specification of symmetry (GO:0009799) | 2.88182946 |
| 103 | mitochondrial calcium ion transport (GO:0006851) | 2.87104204 |
| 104 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.86788716 |
| 105 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.86788716 |
| 106 | positive regulation of p38MAPK cascade (GO:1900745) | 2.86750475 |
| 107 | smoothened signaling pathway (GO:0007224) | 2.86726731 |
| 108 | multicellular organism reproduction (GO:0032504) | 2.86134803 |
| 109 | protein polyglutamylation (GO:0018095) | 2.85999668 |
| 110 | complement activation (GO:0006956) | 2.84291075 |
| 111 | ethanol oxidation (GO:0006069) | 2.82504290 |
| 112 | negative regulation of protein activation cascade (GO:2000258) | 2.82081795 |
| 113 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.81811367 |
| 114 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.81550189 |
| 115 | regulation of leukocyte degranulation (GO:0043300) | 2.80215912 |
| 116 | response to muramyl dipeptide (GO:0032495) | 2.78805145 |
| 117 | rRNA catabolic process (GO:0016075) | 2.75074976 |
| 118 | myeloid cell activation involved in immune response (GO:0002275) | 2.75045293 |
| 119 | adaptation of signaling pathway (GO:0023058) | 2.74694747 |
| 120 | microtubule polymerization or depolymerization (GO:0031109) | 2.72487395 |
| 121 | regulation of mast cell activation (GO:0033003) | 2.71455466 |
| 122 | regulation of interleukin-5 production (GO:0032674) | 2.70822313 |
| 123 | cornea development in camera-type eye (GO:0061303) | 2.70704473 |
| 124 | sperm capacitation (GO:0048240) | 2.70640443 |
| 125 | very long-chain fatty acid metabolic process (GO:0000038) | 2.70114446 |
| 126 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.67773153 |
| 127 | microglial cell activation (GO:0001774) | 2.67710441 |
| 128 | glutathione derivative metabolic process (GO:1901685) | 2.66763748 |
| 129 | glutathione derivative biosynthetic process (GO:1901687) | 2.66763748 |
| 130 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.65778219 |
| 131 | myelin maintenance (GO:0043217) | 2.65284378 |
| 132 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.63672464 |
| 133 | negative regulation of interleukin-17 production (GO:0032700) | 2.63545138 |
| 134 | negative regulation of interleukin-12 production (GO:0032695) | 2.63164447 |
| 135 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.62409812 |
| 136 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.62119785 |
| 137 | regulation of chemokine biosynthetic process (GO:0045073) | 2.61967345 |
| 138 | negative regulation of protein localization to cell surface (GO:2000009) | 2.61521784 |
| 139 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.60215920 |
| 140 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.59135445 |
| 141 | response to fungus (GO:0009620) | 2.59037175 |
| 142 | spinal cord motor neuron differentiation (GO:0021522) | 2.58991345 |
| 143 | L-fucose catabolic process (GO:0042355) | 2.58337160 |
| 144 | fucose catabolic process (GO:0019317) | 2.58337160 |
| 145 | L-fucose metabolic process (GO:0042354) | 2.58337160 |
| 146 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.57918870 |
| 147 | negative regulation of interleukin-2 production (GO:0032703) | 2.56550394 |
| 148 | T-helper 1 type immune response (GO:0042088) | 2.55110676 |
| 149 | lateral ventricle development (GO:0021670) | 2.52800259 |
| 150 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.52251828 |
| 151 | axonemal dynein complex assembly (GO:0070286) | 2.52058134 |
| 152 | DNA deamination (GO:0045006) | 2.51468908 |
| 153 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.50797421 |
| 154 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.49632468 |
| 155 | positive regulation of T cell chemotaxis (GO:0010820) | 2.49514967 |
| 156 | regulation of T cell chemotaxis (GO:0010819) | 2.49514967 |
| 157 | cytoplasmic microtubule organization (GO:0031122) | 2.49272198 |
| 158 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.48232594 |
| 159 | organelle assembly (GO:0070925) | 2.47547424 |
| 160 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.47341100 |
| 161 | xenobiotic catabolic process (GO:0042178) | 2.45033858 |
| 162 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.44370105 |
| 163 | cellular ketone body metabolic process (GO:0046950) | 2.44186878 |
| 164 | positive regulation of B cell differentiation (GO:0045579) | 2.43749268 |
| 165 | regulation of regulated secretory pathway (GO:1903305) | 2.43114761 |
| 166 | response to xenobiotic stimulus (GO:0009410) | 2.42822121 |
| 167 | ethanol metabolic process (GO:0006067) | 2.42801274 |
| 168 | response to pheromone (GO:0019236) | 2.40309905 |
| 169 | lung epithelium development (GO:0060428) | 2.39682036 |
| 170 | neurotransmitter metabolic process (GO:0042133) | 2.37502671 |
| 171 | regulation of interleukin-13 production (GO:0032656) | 2.36889263 |
| 172 | organic cation transport (GO:0015695) | 2.36655427 |
| 173 | appendage development (GO:0048736) | 2.32688531 |
| 174 | limb development (GO:0060173) | 2.32688531 |
| 175 | sialylation (GO:0097503) | 2.32590508 |
| 176 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.30507057 |
| 177 | establishment of monopolar cell polarity (GO:0061162) | 2.30507057 |
| 178 | superoxide anion generation (GO:0042554) | 2.29131866 |
| 179 | establishment of protein localization to Golgi (GO:0072600) | 2.28982006 |
| 180 | negative regulation of adaptive immune response (GO:0002820) | 2.26115879 |
| 181 | microtubule-based process (GO:0007017) | 2.21460249 |
| 182 | benzene-containing compound metabolic process (GO:0042537) | 2.20914494 |
| 183 | retinol metabolic process (GO:0042572) | 2.20682737 |
| 184 | excretion (GO:0007588) | 2.20130267 |
| 185 | phosphatidylcholine biosynthetic process (GO:0006656) | 2.17105678 |
| 186 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.16851883 |
| 187 | photoreceptor cell development (GO:0042461) | 2.15143732 |
| 188 | respiratory chain complex IV assembly (GO:0008535) | 2.14583266 |
| 189 | cilium movement (GO:0003341) | 12.1119061 |
| 190 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 12.0837898 |
| 191 | epithelial cilium movement (GO:0003351) | 11.0043856 |
| 192 | motile cilium assembly (GO:0044458) | 10.2365270 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 4.73611374 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.57200327 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.16703757 |
| 4 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.04367211 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.00948915 |
| 6 | VDR_22108803_ChIP-Seq_LS180_Human | 2.92065675 |
| 7 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.75985787 |
| 8 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.75407879 |
| 9 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.68448935 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.64368804 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.58605776 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.58355648 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.56557230 |
| 14 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.54297086 |
| 15 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.51913970 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.43511577 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.37920500 |
| 18 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.37632517 |
| 19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.37172133 |
| 20 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.20198954 |
| 21 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.19064513 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.17287418 |
| 23 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.11144037 |
| 24 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.10314390 |
| 25 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.03629864 |
| 26 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.02760736 |
| 27 | EWS_26573619_Chip-Seq_HEK293_Human | 1.99608872 |
| 28 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.99140066 |
| 29 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.99140066 |
| 30 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.98585945 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.98391814 |
| 32 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.98086571 |
| 33 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.97928730 |
| 34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.97875161 |
| 35 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.91927698 |
| 36 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.91684803 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.89783377 |
| 38 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.88854976 |
| 39 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.88421546 |
| 40 | FUS_26573619_Chip-Seq_HEK293_Human | 1.87444706 |
| 41 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.85429311 |
| 42 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.84446804 |
| 43 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.83254176 |
| 44 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.82099306 |
| 45 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.80639235 |
| 46 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.80476264 |
| 47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.77440666 |
| 48 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.77211856 |
| 49 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.76051413 |
| 50 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.73779119 |
| 51 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.72956973 |
| 52 | P300_19829295_ChIP-Seq_ESCs_Human | 1.70336918 |
| 53 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.67238884 |
| 54 | STAT3_23295773_ChIP-Seq_U87_Human | 1.66530727 |
| 55 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.60987433 |
| 56 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.59822764 |
| 57 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.59804704 |
| 58 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.57739190 |
| 59 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.55427772 |
| 60 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.55391782 |
| 61 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.54540719 |
| 62 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.54540719 |
| 63 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.53614214 |
| 64 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.52682224 |
| 65 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.52682224 |
| 66 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.51684440 |
| 67 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.51624548 |
| 68 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.49849332 |
| 69 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.49760309 |
| 70 | TCF4_23295773_ChIP-Seq_U87_Human | 1.47553388 |
| 71 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.46152003 |
| 72 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.45094255 |
| 73 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.43679704 |
| 74 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.41249828 |
| 75 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.40937471 |
| 76 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.40678135 |
| 77 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.40652422 |
| 78 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.40398101 |
| 79 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.39341653 |
| 80 | AR_25329375_ChIP-Seq_VCAP_Human | 1.38730847 |
| 81 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.38187820 |
| 82 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.37511548 |
| 83 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.37088705 |
| 84 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.35093064 |
| 85 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.30914624 |
| 86 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.29934415 |
| 87 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.29466264 |
| 88 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.28763847 |
| 89 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.27662280 |
| 90 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.27536490 |
| 91 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.27536490 |
| 92 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.26875358 |
| 93 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.26875358 |
| 94 | GATA1_19941826_ChIP-Seq_K562_Human | 1.26816657 |
| 95 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.26720000 |
| 96 | AR_20517297_ChIP-Seq_VCAP_Human | 1.25822596 |
| 97 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.25720802 |
| 98 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.25581221 |
| 99 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.25072583 |
| 100 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.24641738 |
| 101 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.23739159 |
| 102 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.23610592 |
| 103 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.23014334 |
| 104 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.22283905 |
| 105 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.22121215 |
| 106 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.21967671 |
| 107 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.21465048 |
| 108 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.20218275 |
| 109 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.19740649 |
| 110 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.19592100 |
| 111 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.19476241 |
| 112 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.19201878 |
| 113 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.16518176 |
| 114 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.14386413 |
| 115 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.14308384 |
| 116 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.13220779 |
| 117 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.12688902 |
| 118 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.11690613 |
| 119 | GATA2_19941826_ChIP-Seq_K562_Human | 1.11258739 |
| 120 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.10999335 |
| 121 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.10656010 |
| 122 | NCOR_22424771_ChIP-Seq_293T_Human | 1.10255116 |
| 123 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.09941480 |
| 124 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.09835475 |
| 125 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.09420375 |
| 126 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09045185 |
| 127 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08983856 |
| 128 | MYB_26560356_Chip-Seq_TH2_Human | 1.07903669 |
| 129 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.07543215 |
| 130 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.07081550 |
| 131 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.06969536 |
| 132 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.06547943 |
| 133 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.06476531 |
| 134 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.06386316 |
| 135 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.05998815 |
| 136 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.05634736 |
| 137 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.05460952 |
| 138 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.05292356 |
| 139 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.05149588 |
| 140 | TP53_16413492_ChIP-PET_HCT116_Human | 1.04825694 |
| 141 | NFYA_21822215_ChIP-Seq_K562_Human | 1.04467007 |
| 142 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.04389630 |
| 143 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04356822 |
| 144 | TBL1_22424771_ChIP-Seq_293T_Human | 1.04210394 |
| 145 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.03614242 |
| 146 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.02509564 |
| 147 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.02405998 |
| 148 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01341615 |
| 149 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.01320437 |
| 150 | NFYB_21822215_ChIP-Seq_K562_Human | 1.00943429 |
| 151 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.00594703 |
| 152 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.00504368 |
| 153 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.99821145 |
| 154 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.99681477 |
| 155 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.97221732 |
| 156 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.96704204 |
| 157 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.95639925 |
| 158 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.93645967 |
| 159 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.92432325 |
| 160 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91369546 |
| 161 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91251622 |
| 162 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.90675026 |
| 163 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90162502 |
| 164 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.89236405 |
| 165 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88762393 |
| 166 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88506870 |
| 167 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.88269888 |
| 168 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.87846180 |
| 169 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86725517 |
| 170 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.85070372 |
| 171 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84914571 |
| 172 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.84783913 |
| 173 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84243714 |
| 174 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.84044680 |
| 175 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.83639514 |
| 176 | GATA3_26560356_Chip-Seq_TH2_Human | 0.82923386 |
| 177 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.81595945 |
| 178 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.81451434 |
| 179 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.81451434 |
| 180 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.81413372 |
| 181 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.81258131 |
| 182 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.81067878 |
| 183 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.80456815 |
| 184 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.79612109 |
| 185 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.79137354 |
| 186 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.77817254 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002653_abnormal_ependyma_morphology | 5.08071181 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.79719087 |
| 3 | MP0001984_abnormal_olfaction | 3.01022958 |
| 4 | MP0004043_abnormal_pH_regulation | 2.90856981 |
| 5 | MP0003436_decreased_susceptibility_to | 2.89805414 |
| 6 | MP0003075_altered_response_to | 2.88021757 |
| 7 | MP0005365_abnormal_bile_salt | 2.84659081 |
| 8 | MP0003724_increased_susceptibility_to | 2.82175401 |
| 9 | MP0002009_preneoplasia | 2.73151538 |
| 10 | MP0009785_altered_susceptibility_to | 2.68057607 |
| 11 | MP0003656_abnormal_erythrocyte_physiolo | 2.67679243 |
| 12 | MP0004133_heterotaxia | 2.63301110 |
| 13 | MP0003787_abnormal_imprinting | 2.61147205 |
| 14 | MP0003303_peritoneal_inflammation | 2.59170670 |
| 15 | MP0003950_abnormal_plasma_membrane | 2.58620835 |
| 16 | MP0002419_abnormal_innate_immunity | 2.58448424 |
| 17 | MP0000569_abnormal_digit_pigmentation | 2.55051857 |
| 18 | MP0002166_altered_tumor_susceptibility | 2.40064444 |
| 19 | MP0008877_abnormal_DNA_methylation | 2.39542017 |
| 20 | MP0005164_abnormal_response_to | 2.39334416 |
| 21 | MP0003690_abnormal_glial_cell | 2.38883942 |
| 22 | MP0008875_abnormal_xenobiotic_pharmacok | 2.32680371 |
| 23 | MP0004883_abnormal_blood_vessel | 2.24857721 |
| 24 | MP0005083_abnormal_biliary_tract | 2.24213529 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 2.18066351 |
| 26 | MP0005551_abnormal_eye_electrophysiolog | 2.17361205 |
| 27 | MP0005058_abnormal_lysosome_morphology | 2.12878293 |
| 28 | MP0002006_tumorigenesis | 2.11501120 |
| 29 | MP0000920_abnormal_myelination | 2.10909826 |
| 30 | MP0003195_calcinosis | 2.08612604 |
| 31 | MP0002132_abnormal_respiratory_system | 2.08074324 |
| 32 | MP0008789_abnormal_olfactory_epithelium | 1.98664884 |
| 33 | MP0005000_abnormal_immune_tolerance | 1.98282594 |
| 34 | MP0005085_abnormal_gallbladder_physiolo | 1.97656230 |
| 35 | MP0002876_abnormal_thyroid_physiology | 1.97030468 |
| 36 | MP0001853_heart_inflammation | 1.96547483 |
| 37 | MP0009764_decreased_sensitivity_to | 1.94051038 |
| 38 | MP0005025_abnormal_response_to | 1.93346822 |
| 39 | MP0005671_abnormal_response_to | 1.85942971 |
| 40 | MP0002102_abnormal_ear_morphology | 1.85122778 |
| 41 | MP0008872_abnormal_physiological_respon | 1.84404475 |
| 42 | MP0000383_abnormal_hair_follicle | 1.84234506 |
| 43 | MP0003191_abnormal_cellular_cholesterol | 1.84156148 |
| 44 | MP0009046_muscle_twitch | 1.82135250 |
| 45 | MP0002148_abnormal_hypersensitivity_rea | 1.79654429 |
| 46 | MP0005645_abnormal_hypothalamus_physiol | 1.78757776 |
| 47 | MP0001790_abnormal_immune_system | 1.78662370 |
| 48 | MP0005387_immune_system_phenotype | 1.78662370 |
| 49 | MP0001835_abnormal_antigen_presentation | 1.78059394 |
| 50 | MP0000343_altered_response_to | 1.72611325 |
| 51 | MP0005166_decreased_susceptibility_to | 1.69792004 |
| 52 | MP0005377_hearing/vestibular/ear_phenot | 1.67935116 |
| 53 | MP0003878_abnormal_ear_physiology | 1.67935116 |
| 54 | MP0000604_amyloidosis | 1.66212065 |
| 55 | MP0002452_abnormal_antigen_presenting | 1.65419432 |
| 56 | MP0003329_amyloid_beta_deposits | 1.59485072 |
| 57 | MP0001968_abnormal_touch/_nociception | 1.59180861 |
| 58 | MP0001800_abnormal_humoral_immune | 1.57560713 |
| 59 | MP0005464_abnormal_platelet_physiology | 1.53084685 |
| 60 | MP0003448_altered_tumor_morphology | 1.51647193 |
| 61 | MP0002420_abnormal_adaptive_immunity | 1.50653077 |
| 62 | MP0001819_abnormal_immune_cell | 1.49439216 |
| 63 | MP0005646_abnormal_pituitary_gland | 1.48802836 |
| 64 | MP0002160_abnormal_reproductive_system | 1.47934993 |
| 65 | MP0001485_abnormal_pinna_reflex | 1.46934771 |
| 66 | MP0002909_abnormal_adrenal_gland | 1.46860532 |
| 67 | MP0005451_abnormal_body_composition | 1.46570266 |
| 68 | MP0002933_joint_inflammation | 1.45964159 |
| 69 | MP0001533_abnormal_skeleton_physiology | 1.45486862 |
| 70 | MP0005253_abnormal_eye_physiology | 1.44493613 |
| 71 | MP0001765_abnormal_ion_homeostasis | 1.43311813 |
| 72 | MP0005360_urolithiasis | 1.43191784 |
| 73 | MP0003186_abnormal_redox_activity | 1.41609962 |
| 74 | MP0001845_abnormal_inflammatory_respons | 1.41042489 |
| 75 | MP0000427_abnormal_hair_cycle | 1.40492027 |
| 76 | MP0002723_abnormal_immune_serum | 1.40451184 |
| 77 | MP0004782_abnormal_surfactant_physiolog | 1.40225089 |
| 78 | MP0001986_abnormal_taste_sensitivity | 1.38551398 |
| 79 | MP0002736_abnormal_nociception_after | 1.37841975 |
| 80 | MP0005174_abnormal_tail_pigmentation | 1.36276091 |
| 81 | MP0010234_abnormal_vibrissa_follicle | 1.32073820 |
| 82 | MP0002277_abnormal_respiratory_mucosa | 1.31511094 |
| 83 | MP0009745_abnormal_behavioral_response | 1.29492409 |
| 84 | MP0002168_other_aberrant_phenotype | 1.26457371 |
| 85 | MP0005394_taste/olfaction_phenotype | 1.25505915 |
| 86 | MP0005499_abnormal_olfactory_system | 1.25505915 |
| 87 | MP0005389_reproductive_system_phenotype | 1.22734737 |
| 88 | MP0002735_abnormal_chemical_nociception | 1.21100291 |
| 89 | MP0010678_abnormal_skin_adnexa | 1.19637145 |
| 90 | MP0001529_abnormal_vocalization | 1.18918551 |
| 91 | MP0001486_abnormal_startle_reflex | 1.18562248 |
| 92 | MP0002998_abnormal_bone_remodeling | 1.18359443 |
| 93 | MP0002638_abnormal_pupillary_reflex | 1.18248546 |
| 94 | MP0005636_abnormal_mineral_homeostasis | 1.17343765 |
| 95 | MP0000631_abnormal_neuroendocrine_gland | 1.17231720 |
| 96 | MP0008469_abnormal_protein_level | 1.15583728 |
| 97 | MP0000858_altered_metastatic_potential | 1.14948263 |
| 98 | MP0002928_abnormal_bile_duct | 1.13158580 |
| 99 | MP0003828_pulmonary_edema | 1.12824325 |
| 100 | MP0001970_abnormal_pain_threshold | 1.12241879 |
| 101 | MP0005187_abnormal_penis_morphology | 1.11829039 |
| 102 | MP0004019_abnormal_vitamin_homeostasis | 1.10853379 |
| 103 | MP0003646_muscle_fatigue | 1.10519549 |
| 104 | MP0001958_emphysema | 1.10130236 |
| 105 | MP0005332_abnormal_amino_acid | 1.10042417 |
| 106 | MP0004142_abnormal_muscle_tone | 1.08707828 |
| 107 | MP0002272_abnormal_nervous_system | 1.08294361 |
| 108 | MP0004885_abnormal_endolymph | 1.05508793 |
| 109 | MP0003698_abnormal_male_reproductive | 1.05415085 |
| 110 | MP0010155_abnormal_intestine_physiology | 1.05352888 |
| 111 | MP0005310_abnormal_salivary_gland | 1.04009463 |
| 112 | MP0000716_abnormal_immune_system | 1.03912204 |
| 113 | MP0003183_abnormal_peptide_metabolism | 1.03784649 |
| 114 | MP0002734_abnormal_mechanical_nocicepti | 1.03172929 |
| 115 | MP0002163_abnormal_gland_morphology | 1.02896856 |
| 116 | MP0001849_ear_inflammation | 1.02256508 |
| 117 | MP0002090_abnormal_vision | 1.01412232 |
| 118 | MP0003633_abnormal_nervous_system | 1.00907850 |
| 119 | MP0005084_abnormal_gallbladder_morpholo | 1.00232524 |
| 120 | MP0008995_early_reproductive_senescence | 1.00080259 |
| 121 | MP0001851_eye_inflammation | 0.99543062 |
| 122 | MP0010329_abnormal_lipoprotein_level | 0.98522092 |
| 123 | MP0003045_fibrosis | 0.98371208 |
| 124 | MP0000685_abnormal_immune_system | 0.97952938 |
| 125 | MP0009763_increased_sensitivity_to | 0.97187172 |
| 126 | MP0005167_abnormal_blood-brain_barrier | 0.96884726 |
| 127 | MP0003136_yellow_coat_color | 0.96300356 |
| 128 | MP0006082_CNS_inflammation | 0.95184956 |
| 129 | MP0003566_abnormal_cell_adhesion | 0.94917484 |
| 130 | MP0006072_abnormal_retinal_apoptosis | 0.94303163 |
| 131 | MP0002254_reproductive_system_inflammat | 0.94226785 |
| 132 | MP0000465_gastrointestinal_hemorrhage | 0.93375025 |
| 133 | MP0002282_abnormal_trachea_morphology | 0.93335531 |
| 134 | MP0001542_abnormal_bone_strength | 0.92020259 |
| 135 | MP0002229_neurodegeneration | 0.91820591 |
| 136 | MP0003011_delayed_dark_adaptation | 0.91742629 |
| 137 | MP0009379_abnormal_foot_pigmentation | 0.91582422 |
| 138 | MP0002118_abnormal_lipid_homeostasis | 0.91429707 |
| 139 | MP0001929_abnormal_gametogenesis | 0.90577612 |
| 140 | MP0001545_abnormal_hematopoietic_system | 0.89525861 |
| 141 | MP0005397_hematopoietic_system_phenotyp | 0.89525861 |
| 142 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.89519661 |
| 143 | MP0003091_abnormal_cell_migration | 0.89115190 |
| 144 | MP0001666_abnormal_nutrient_absorption | 0.89113408 |
| 145 | MP0002398_abnormal_bone_marrow | 0.88246536 |
| 146 | MP0002837_dystrophic_cardiac_calcinosis | 0.87834623 |
| 147 | MP0004264_abnormal_extraembryonic_tissu | 0.87087098 |
| 148 | MP0003632_abnormal_nervous_system | 0.86972373 |
| 149 | MP0004147_increased_porphyrin_level | 0.85993999 |
| 150 | MP0005395_other_phenotype | 0.85404547 |
| 151 | MP0005408_hypopigmentation | 0.84647703 |
| 152 | MP0002067_abnormal_sensory_capabilities | 0.83499545 |
| 153 | MP0003121_genomic_imprinting | 0.83183275 |
| 154 | MP0002572_abnormal_emotion/affect_behav | 0.82949486 |
| 155 | MP0004947_skin_inflammation | 0.82213028 |
| 156 | MP0002396_abnormal_hematopoietic_system | 0.81782551 |
| 157 | MP0005195_abnormal_posterior_eye | 0.81286903 |
| 158 | MP0000647_abnormal_sebaceous_gland | 0.81168678 |
| 159 | MP0000609_abnormal_liver_physiology | 0.80989470 |
| 160 | MP0002557_abnormal_social/conspecific_i | 0.80545052 |
| 161 | MP0009333_abnormal_splenocyte_physiolog | 0.79673423 |
| 162 | MP0002405_respiratory_system_inflammati | 0.79603261 |
| 163 | MP0004185_abnormal_adipocyte_glucose | 0.78924608 |
| 164 | MP0004742_abnormal_vestibular_system | 0.78872831 |
| 165 | MP0003631_nervous_system_phenotype | 0.78675713 |
| 166 | MP0005165_increased_susceptibility_to | 0.77187833 |
| 167 | MP0005023_abnormal_wound_healing | 0.76286217 |
| 168 | MP0006276_abnormal_autonomic_nervous | 0.76203117 |
| 169 | MP0001502_abnormal_circadian_rhythm | 0.76095201 |
| 170 | MP0004215_abnormal_myocardial_fiber | 0.76071874 |
| 171 | MP0002095_abnormal_skin_pigmentation | 0.74738332 |
| 172 | MP0002429_abnormal_blood_cell | 0.73912808 |
| 173 | MP0004484_altered_response_of | 0.73474618 |
| 174 | MP0005410_abnormal_fertilization | 0.72202295 |
| 175 | MP0003866_abnormal_defecation | 0.72173977 |
| 176 | MP0005386_behavior/neurological_phenoty | 0.71648082 |
| 177 | MP0004924_abnormal_behavior | 0.71648082 |
| 178 | MP0001919_abnormal_reproductive_system | 0.71347229 |
| 179 | MP0001188_hyperpigmentation | 0.69716609 |
| 180 | MP0000026_abnormal_inner_ear | 0.68785758 |
| 181 | MP0002064_seizures | 0.67949949 |
| 182 | MP0000230_abnormal_systemic_arterial | 0.67609631 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Absent/shortened dynein arms (HP:0200106) | 9.64299442 |
| 2 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 9.64299442 |
| 3 | Abnormal respiratory motile cilium physiology (HP:0012261) | 9.10651185 |
| 4 | Rhinitis (HP:0012384) | 8.37388495 |
| 5 | Bronchiectasis (HP:0002110) | 6.16711959 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.34693321 |
| 7 | Chronic otitis media (HP:0000389) | 5.30563901 |
| 8 | Recurrent abscess formation (HP:0002722) | 4.90433572 |
| 9 | Abnormality of macrophages (HP:0004311) | 4.90291656 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 4.79985436 |
| 11 | Hypochromic microcytic anemia (HP:0004840) | 4.50877824 |
| 12 | Pancreatic fibrosis (HP:0100732) | 4.44576990 |
| 13 | Eczematoid dermatitis (HP:0000976) | 4.30876775 |
| 14 | True hermaphroditism (HP:0010459) | 4.29145015 |
| 15 | Pancreatic cysts (HP:0001737) | 4.17279206 |
| 16 | Orchitis (HP:0100796) | 3.98681920 |
| 17 | Myositis (HP:0100614) | 3.91668174 |
| 18 | Molar tooth sign on MRI (HP:0002419) | 3.88099203 |
| 19 | Abnormality of midbrain morphology (HP:0002418) | 3.88099203 |
| 20 | Enlarged kidneys (HP:0000105) | 3.74935829 |
| 21 | Nephronophthisis (HP:0000090) | 3.73394893 |
| 22 | Chronic sinusitis (HP:0011109) | 3.62223393 |
| 23 | Infertility (HP:0000789) | 3.52691791 |
| 24 | Retrobulbar optic neuritis (HP:0100654) | 3.49071370 |
| 25 | Optic neuritis (HP:0100653) | 3.49071370 |
| 26 | Neurofibrillary tangles (HP:0002185) | 3.44803064 |
| 27 | Recurrent sinusitis (HP:0011108) | 3.31666255 |
| 28 | Occipital encephalocele (HP:0002085) | 3.28541570 |
| 29 | Cystic liver disease (HP:0006706) | 3.16822591 |
| 30 | Abnormality of the renal medulla (HP:0100957) | 3.07020634 |
| 31 | Cellulitis (HP:0100658) | 3.03522254 |
| 32 | Chronic hepatic failure (HP:0100626) | 3.01566578 |
| 33 | Interstitial pulmonary disease (HP:0006530) | 2.98347491 |
| 34 | Medial flaring of the eyebrow (HP:0010747) | 2.95268151 |
| 35 | Abnormality of the common coagulation pathway (HP:0010990) | 2.91153759 |
| 36 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.90967487 |
| 37 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.90967487 |
| 38 | Spontaneous hematomas (HP:0007420) | 2.89829913 |
| 39 | Recurrent skin infections (HP:0001581) | 2.89491724 |
| 40 | Hyperlipoproteinemia (HP:0010980) | 2.87298138 |
| 41 | Postaxial foot polydactyly (HP:0001830) | 2.80693153 |
| 42 | Severe Myopia (HP:0011003) | 2.79281561 |
| 43 | Male infertility (HP:0003251) | 2.76422912 |
| 44 | Xanthomatosis (HP:0000991) | 2.76269556 |
| 45 | Recurrent otitis media (HP:0000403) | 2.75986912 |
| 46 | Joint hemorrhage (HP:0005261) | 2.75381145 |
| 47 | Clumsiness (HP:0002312) | 2.73655726 |
| 48 | Anencephaly (HP:0002323) | 2.65744602 |
| 49 | Disinhibition (HP:0000734) | 2.61607349 |
| 50 | Gingivitis (HP:0000230) | 2.56521533 |
| 51 | Hypochromic anemia (HP:0001931) | 2.52614347 |
| 52 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.52151005 |
| 53 | Intrahepatic cholestasis (HP:0001406) | 2.51471855 |
| 54 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.50730727 |
| 55 | Pustule (HP:0200039) | 2.50313224 |
| 56 | Periodontitis (HP:0000704) | 2.49185524 |
| 57 | Meningitis (HP:0001287) | 2.45544457 |
| 58 | Amyloidosis (HP:0011034) | 2.45541005 |
| 59 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.43630234 |
| 60 | Osteomyelitis (HP:0002754) | 2.42830029 |
| 61 | Congenital hepatic fibrosis (HP:0002612) | 2.42684022 |
| 62 | Congenital primary aphakia (HP:0007707) | 2.42532616 |
| 63 | Gait imbalance (HP:0002141) | 2.42314202 |
| 64 | Cerebral inclusion bodies (HP:0100314) | 2.39349242 |
| 65 | Chronic bronchitis (HP:0004469) | 2.39205876 |
| 66 | Pulmonary embolism (HP:0002204) | 2.34453528 |
| 67 | Male pseudohermaphroditism (HP:0000037) | 2.33439381 |
| 68 | Loss of speech (HP:0002371) | 2.32159089 |
| 69 | Keratoconjunctivitis sicca (HP:0001097) | 2.32072776 |
| 70 | Chronic obstructive pulmonary disease (HP:0006510) | 2.31971067 |
| 71 | Obstructive lung disease (HP:0006536) | 2.31971067 |
| 72 | Nasal polyposis (HP:0100582) | 2.31601648 |
| 73 | Mediastinal lymphadenopathy (HP:0100721) | 2.31485333 |
| 74 | Decreased central vision (HP:0007663) | 2.30387838 |
| 75 | Hematochezia (HP:0002573) | 2.29997904 |
| 76 | Furrowed tongue (HP:0000221) | 2.29526577 |
| 77 | Deep venous thrombosis (HP:0002625) | 2.29233172 |
| 78 | Abnormality of the renal cortex (HP:0011035) | 2.27376448 |
| 79 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.26901289 |
| 80 | Nephrogenic diabetes insipidus (HP:0009806) | 2.24444047 |
| 81 | Tubular atrophy (HP:0000092) | 2.23318047 |
| 82 | Sclerocornea (HP:0000647) | 2.23140329 |
| 83 | Abnormality of the nasal mucosa (HP:0000433) | 2.19036118 |
| 84 | Pulmonic stenosis (HP:0001642) | 2.17704028 |
| 85 | Recurrent pneumonia (HP:0006532) | 2.16591326 |
| 86 | Gingival bleeding (HP:0000225) | 2.15426637 |
| 87 | Decreased circulating renin level (HP:0003351) | 2.15072827 |
| 88 | Intention tremor (HP:0002080) | 2.15016028 |
| 89 | Pulmonary infiltrates (HP:0002113) | 2.14390351 |
| 90 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.13377165 |
| 91 | Gout (HP:0001997) | 2.12679308 |
| 92 | Systemic lupus erythematosus (HP:0002725) | 2.10512130 |
| 93 | Vasculitis (HP:0002633) | 2.09880209 |
| 94 | Sepsis (HP:0100806) | 2.06306980 |
| 95 | Dysostosis multiplex (HP:0000943) | 2.06004627 |
| 96 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.05675254 |
| 97 | Keratoconjunctivitis (HP:0001096) | 2.04573045 |
| 98 | Aortic valve stenosis (HP:0001650) | 2.04266668 |
| 99 | Increased cerebral lipofuscin (HP:0011813) | 2.04040929 |
| 100 | Eosinophilia (HP:0001880) | 2.02780683 |
| 101 | Esophageal atresia (HP:0002032) | 2.01866771 |
| 102 | Clitoromegaly (HP:0000057) | 1.99301680 |
| 103 | Leukocytosis (HP:0001974) | 1.96946206 |
| 104 | Postaxial hand polydactyly (HP:0001162) | 1.95836697 |
| 105 | Recurrent viral infections (HP:0004429) | 1.95532571 |
| 106 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.93745823 |
| 107 | Tubulointerstitial nephritis (HP:0001970) | 1.93535034 |
| 108 | Increased serum ferritin (HP:0003281) | 1.92611618 |
| 109 | Termporal pattern (HP:0011008) | 1.92025799 |
| 110 | Insidious onset (HP:0003587) | 1.92025799 |
| 111 | Arterial thrombosis (HP:0004420) | 1.90292784 |
| 112 | Abnormality of iron homeostasis (HP:0011031) | 1.90111785 |
| 113 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.88658182 |
| 114 | Glomerulonephritis (HP:0000099) | 1.88618520 |
| 115 | Bronchitis (HP:0012387) | 1.88343158 |
| 116 | Prolonged partial thromboplastin time (HP:0003645) | 1.88241994 |
| 117 | Abnormal drinking behavior (HP:0030082) | 1.87286703 |
| 118 | Polydipsia (HP:0001959) | 1.87286703 |
| 119 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.87251115 |
| 120 | Genital tract atresia (HP:0001827) | 1.85979552 |
| 121 | Inappropriate behavior (HP:0000719) | 1.85844211 |
| 122 | Urticaria (HP:0001025) | 1.85142454 |
| 123 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.83724159 |
| 124 | Bifid scrotum (HP:0000048) | 1.83331864 |
| 125 | Prolonged neonatal jaundice (HP:0006579) | 1.83217003 |
| 126 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.82112442 |
| 127 | Infantile muscular hypotonia (HP:0008947) | 1.82044580 |
| 128 | Pancreatitis (HP:0001733) | 1.81222741 |
| 129 | Recurrent fungal infections (HP:0002841) | 1.81121535 |
| 130 | Asplenia (HP:0001746) | 1.80873360 |
| 131 | Complement deficiency (HP:0004431) | 1.80650844 |
| 132 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.80409571 |
| 133 | Gastrointestinal stroma tumor (HP:0100723) | 1.80180923 |
| 134 | Vaginal atresia (HP:0000148) | 1.78759613 |
| 135 | Hyperactive renin-angiotensin system (HP:0000841) | 1.78487347 |
| 136 | Oculomotor apraxia (HP:0000657) | 1.78197876 |
| 137 | Hypertriglyceridemia (HP:0002155) | 1.77967410 |
| 138 | Mutism (HP:0002300) | 1.77525127 |
| 139 | Abnormal ciliary motility (HP:0012262) | 1.76919197 |
| 140 | Poor coordination (HP:0002370) | 1.76484992 |
| 141 | Broad metatarsal (HP:0001783) | 1.75539436 |
| 142 | Supranuclear gaze palsy (HP:0000605) | 1.74950563 |
| 143 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.72656450 |
| 144 | Hepatosplenomegaly (HP:0001433) | 1.72016020 |
| 145 | Attenuation of retinal blood vessels (HP:0007843) | 1.69541658 |
| 146 | Thyroiditis (HP:0100646) | 1.69342404 |
| 147 | Recurrent bronchitis (HP:0002837) | 1.67308610 |
| 148 | Absent speech (HP:0001344) | 1.64942206 |
| 149 | Congenital stationary night blindness (HP:0007642) | 1.63943646 |
| 150 | Abnormality of macular pigmentation (HP:0008002) | 1.63032061 |
| 151 | Hyperventilation (HP:0002883) | 1.59046229 |
| 152 | Nephropathy (HP:0000112) | 1.55321559 |
| 153 | Abolished electroretinogram (ERG) (HP:0000550) | 1.55168488 |
| 154 | Type II lissencephaly (HP:0007260) | 1.52896529 |
| 155 | Disproportionate short-trunk short stature (HP:0003521) | 1.50293815 |
| 156 | Preaxial hand polydactyly (HP:0001177) | 1.45280051 |
| 157 | Renal salt wasting (HP:0000127) | 1.44106500 |
| 158 | Broad-based gait (HP:0002136) | 1.44091806 |
| 159 | Gaze-evoked nystagmus (HP:0000640) | 1.43074168 |
| 160 | Abnormality of renin-angiotensin system (HP:0000847) | 1.42738991 |
| 161 | Atelectasis (HP:0100750) | 1.41287738 |
| 162 | Median cleft lip (HP:0000161) | 1.36449100 |
| 163 | Hyperkalemia (HP:0002153) | 1.36173669 |
| 164 | Stage 5 chronic kidney disease (HP:0003774) | 1.35703506 |
| 165 | Hyperaldosteronism (HP:0000859) | 1.34935407 |
| 166 | Increased corneal curvature (HP:0100692) | 1.34625430 |
| 167 | Keratoconus (HP:0000563) | 1.34625430 |
| 168 | Pendular nystagmus (HP:0012043) | 1.34358552 |
| 169 | Retinitis pigmentosa (HP:0000510) | 1.33523735 |
| 170 | Polyuria (HP:0000103) | 1.33471638 |
| 171 | Hypokalemic alkalosis (HP:0001949) | 1.31936327 |
| 172 | Widely spaced teeth (HP:0000687) | 1.31738716 |
| 173 | Renal cortical cysts (HP:0000803) | 1.31525291 |
| 174 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.30699176 |
| 175 | Narrow forehead (HP:0000341) | 1.30075644 |
| 176 | Carpal bone hypoplasia (HP:0001498) | 1.29389070 |
| 177 | Hip dysplasia (HP:0001385) | 1.27915310 |
| 178 | Tubulointerstitial abnormality (HP:0001969) | 1.26449110 |
| 179 | Specific learning disability (HP:0001328) | 1.23620568 |
| 180 | Multicystic kidney dysplasia (HP:0000003) | 1.21506129 |
| 181 | Aganglionic megacolon (HP:0002251) | 1.20478132 |
| 182 | Abnormality of chloride homeostasis (HP:0011422) | 1.20445608 |
| 183 | Prominent nasal bridge (HP:0000426) | 1.20090685 |
| 184 | Constricted visual fields (HP:0001133) | 1.19255360 |
| 185 | Abnormal biliary tract physiology (HP:0012439) | 1.15627215 |
| 186 | Bile duct proliferation (HP:0001408) | 1.15627215 |
| 187 | Agitation (HP:0000713) | 1.15320213 |
| 188 | Barrel-shaped chest (HP:0001552) | 1.14911392 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 5.73719222 |
| 2 | FGFR2 | 5.61504772 |
| 3 | MST4 | 5.14277001 |
| 4 | RIPK4 | 4.06295441 |
| 5 | ERN1 | 3.74935754 |
| 6 | FGFR4 | 3.03529574 |
| 7 | GRK7 | 2.85475761 |
| 8 | MAP3K10 | 2.70515681 |
| 9 | EPHB1 | 2.41172957 |
| 10 | ADRBK2 | 2.38745086 |
| 11 | MAP3K14 | 2.35871760 |
| 12 | TGFBR2 | 2.27056546 |
| 13 | MAP3K4 | 2.21250808 |
| 14 | ITK | 2.20054048 |
| 15 | ZAP70 | 2.18361070 |
| 16 | YES1 | 2.14730660 |
| 17 | TYRO3 | 2.13460034 |
| 18 | FGFR3 | 2.09215522 |
| 19 | PNCK | 2.01520797 |
| 20 | ACVR1B | 2.00523514 |
| 21 | INSRR | 1.90938433 |
| 22 | PTK2B | 1.82193891 |
| 23 | TLK1 | 1.76457259 |
| 24 | MAPKAPK3 | 1.73369248 |
| 25 | GRK1 | 1.71926623 |
| 26 | WNK4 | 1.71114380 |
| 27 | MAP4K2 | 1.58377506 |
| 28 | WNK3 | 1.55320725 |
| 29 | NUAK1 | 1.53680308 |
| 30 | CAMKK2 | 1.53252033 |
| 31 | ZAK | 1.39970291 |
| 32 | PDGFRB | 1.36527412 |
| 33 | MAP4K1 | 1.35780241 |
| 34 | LATS1 | 1.31251470 |
| 35 | MAPK13 | 1.30788795 |
| 36 | STK10 | 1.30410313 |
| 37 | TNIK | 1.21775282 |
| 38 | PIM2 | 1.21537841 |
| 39 | STK24 | 1.21418224 |
| 40 | MAPK7 | 1.17886530 |
| 41 | NTRK2 | 1.14157973 |
| 42 | TEC | 1.12212096 |
| 43 | FRK | 1.11182029 |
| 44 | PAK3 | 1.10461237 |
| 45 | HCK | 1.10250906 |
| 46 | SYK | 1.09744119 |
| 47 | PDGFRA | 1.09229582 |
| 48 | ERBB3 | 1.08429442 |
| 49 | MAP2K3 | 1.08374214 |
| 50 | JAK2 | 1.03514211 |
| 51 | ADRBK1 | 1.02708698 |
| 52 | CAMK1G | 1.01955895 |
| 53 | TBK1 | 0.99753932 |
| 54 | TXK | 0.99403651 |
| 55 | MAP2K7 | 0.99025947 |
| 56 | CLK1 | 0.98600715 |
| 57 | NLK | 0.97851728 |
| 58 | STK3 | 0.97456123 |
| 59 | NME1 | 0.96320309 |
| 60 | LYN | 0.95613845 |
| 61 | CSK | 0.94687452 |
| 62 | EPHA4 | 0.90509860 |
| 63 | PRPF4B | 0.89256376 |
| 64 | BMPR1B | 0.89136210 |
| 65 | TYK2 | 0.87972576 |
| 66 | BRSK2 | 0.87822682 |
| 67 | MAPK4 | 0.87806135 |
| 68 | CASK | 0.86730307 |
| 69 | EPHA2 | 0.85822947 |
| 70 | MKNK2 | 0.84870507 |
| 71 | IRAK1 | 0.81911370 |
| 72 | CAMK1D | 0.81862019 |
| 73 | STK11 | 0.81742868 |
| 74 | LRRK2 | 0.81188699 |
| 75 | JAK1 | 0.80521502 |
| 76 | UHMK1 | 0.80233000 |
| 77 | CAMK2B | 0.80195488 |
| 78 | TRPM7 | 0.79979203 |
| 79 | MAP3K3 | 0.79690868 |
| 80 | TAOK3 | 0.78530744 |
| 81 | SIK3 | 0.76702370 |
| 82 | BTK | 0.76315712 |
| 83 | ERBB2 | 0.75543441 |
| 84 | GRK6 | 0.74589849 |
| 85 | MAP3K2 | 0.74147759 |
| 86 | EGFR | 0.73591523 |
| 87 | PINK1 | 0.73362203 |
| 88 | MAP2K6 | 0.73232396 |
| 89 | MAP3K13 | 0.73148062 |
| 90 | ABL2 | 0.71799708 |
| 91 | LCK | 0.71672019 |
| 92 | ILK | 0.69176064 |
| 93 | MAP2K4 | 0.67290920 |
| 94 | NTRK3 | 0.66923624 |
| 95 | PKN1 | 0.66922604 |
| 96 | CAMKK1 | 0.66023761 |
| 97 | OXSR1 | 0.64809419 |
| 98 | LIMK1 | 0.64786823 |
| 99 | SIK1 | 0.64623109 |
| 100 | SGK2 | 0.63491771 |
| 101 | FYN | 0.63438095 |
| 102 | PRKCQ | 0.62921971 |
| 103 | MELK | 0.62795524 |
| 104 | ABL1 | 0.62317434 |
| 105 | BCKDK | 0.62228492 |
| 106 | IKBKE | 0.61001178 |
| 107 | CAMK2G | 0.60313816 |
| 108 | GSK3A | 0.59671805 |
| 109 | PDK1 | 0.59461134 |
| 110 | PRKCI | 0.59170597 |
| 111 | MARK3 | 0.58359497 |
| 112 | DYRK1A | 0.56705088 |
| 113 | PRKCZ | 0.56253735 |
| 114 | PIK3CG | 0.55779864 |
| 115 | DAPK2 | 0.55082878 |
| 116 | DDR2 | 0.54942533 |
| 117 | PRKCE | 0.54179774 |
| 118 | CSNK1G2 | 0.54034890 |
| 119 | TRIM28 | 0.53353311 |
| 120 | ROCK2 | 0.52328212 |
| 121 | PDPK1 | 0.52309033 |
| 122 | BCR | 0.51843390 |
| 123 | PRKD1 | 0.51778679 |
| 124 | MAP3K12 | 0.51306281 |
| 125 | DYRK3 | 0.51139071 |
| 126 | PIM1 | 0.50577064 |
| 127 | CHUK | 0.50550677 |
| 128 | MAP2K2 | 0.50061528 |
| 129 | STK16 | 0.49689493 |
| 130 | MAP3K6 | 0.49367977 |
| 131 | PHKG2 | 0.49279866 |
| 132 | PHKG1 | 0.49279866 |
| 133 | PLK2 | 0.49054471 |
| 134 | CSNK1A1L | 0.48104992 |
| 135 | FES | 0.47626817 |
| 136 | PRKACA | 0.46251093 |
| 137 | DYRK2 | 0.45661414 |
| 138 | IRAK4 | 0.45366756 |
| 139 | STK39 | 0.45358070 |
| 140 | CAMK1 | 0.44650887 |
| 141 | IGF1R | 0.43446782 |
| 142 | FGR | 0.42736910 |
| 143 | TSSK6 | 0.42711700 |
| 144 | SGK1 | 0.42241276 |
| 145 | PRKG1 | 0.41992904 |
| 146 | CAMK2A | 0.41866862 |
| 147 | TTK | 0.41216293 |
| 148 | IKBKB | 0.40992163 |
| 149 | CAMK4 | 0.40956072 |
| 150 | STK38L | 0.40938043 |
| 151 | EPHA3 | 0.40455449 |
| 152 | PDK2 | 0.39010015 |
| 153 | PRKCG | 0.38794267 |
| 154 | FER | 0.37919211 |
| 155 | PRKAA2 | 0.37858049 |
| 156 | CSNK1G3 | 0.37774833 |
| 157 | PRKCD | 0.37127705 |
| 158 | EIF2AK2 | 0.36645470 |
| 159 | CSNK1G1 | 0.36424565 |
| 160 | MYLK | 0.36284213 |
| 161 | SGK494 | 0.36185385 |
| 162 | SGK223 | 0.36185385 |
| 163 | PLK3 | 0.36069521 |
| 164 | WNK1 | 0.35888996 |
| 165 | MARK1 | 0.35815328 |
| 166 | MINK1 | 0.35556527 |
| 167 | BMPR2 | 0.34410264 |
| 168 | PRKCA | 0.34250174 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.06147506 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.05334866 |
| 3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.87163947 |
| 4 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.71929680 |
| 5 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.63384723 |
| 6 | Huntingtons disease_Homo sapiens_hsa05016 | 2.55229030 |
| 7 | Phototransduction_Homo sapiens_hsa04744 | 2.54897144 |
| 8 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.36899117 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.21482999 |
| 10 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.20629374 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.19276178 |
| 12 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.00419419 |
| 13 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.93726412 |
| 14 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.93129560 |
| 15 | Malaria_Homo sapiens_hsa05144 | 1.81966333 |
| 16 | Pertussis_Homo sapiens_hsa05133 | 1.77061386 |
| 17 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.72742350 |
| 18 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.70421288 |
| 19 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.67369412 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.67254122 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.64512578 |
| 22 | Nicotine addiction_Homo sapiens_hsa05033 | 1.63599667 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.63377549 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.61313194 |
| 25 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.61246573 |
| 26 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.60550210 |
| 27 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.58625724 |
| 28 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.58559158 |
| 29 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.58492531 |
| 30 | Phagosome_Homo sapiens_hsa04145 | 1.58380575 |
| 31 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.58318440 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.52296091 |
| 33 | Basal transcription factors_Homo sapiens_hsa03022 | 1.51285989 |
| 34 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.49744011 |
| 35 | Olfactory transduction_Homo sapiens_hsa04740 | 1.49206847 |
| 36 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.47924365 |
| 37 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.43469703 |
| 38 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.43269043 |
| 39 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.36466348 |
| 40 | Taste transduction_Homo sapiens_hsa04742 | 1.34867425 |
| 41 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.31202622 |
| 42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.30746463 |
| 43 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.29529562 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.28862158 |
| 45 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.28534808 |
| 46 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.25986250 |
| 47 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.25558215 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.23828538 |
| 49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.21901487 |
| 50 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.21719883 |
| 51 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.20680418 |
| 52 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.17822980 |
| 53 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.16483857 |
| 54 | Shigellosis_Homo sapiens_hsa05131 | 1.15161128 |
| 55 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.13815855 |
| 56 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.13122293 |
| 57 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.10537390 |
| 58 | Lysosome_Homo sapiens_hsa04142 | 1.08947835 |
| 59 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.08393500 |
| 60 | Salivary secretion_Homo sapiens_hsa04970 | 1.06609513 |
| 61 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.05832833 |
| 62 | Parkinsons disease_Homo sapiens_hsa05012 | 1.04487797 |
| 63 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.01928703 |
| 64 | Tuberculosis_Homo sapiens_hsa05152 | 1.01035504 |
| 65 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.99870418 |
| 66 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.99445780 |
| 67 | Salmonella infection_Homo sapiens_hsa05132 | 0.99024125 |
| 68 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.98984950 |
| 69 | Circadian rhythm_Homo sapiens_hsa04710 | 0.98816882 |
| 70 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98697128 |
| 71 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.96939856 |
| 72 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.95193479 |
| 73 | Legionellosis_Homo sapiens_hsa05134 | 0.93429504 |
| 74 | Homologous recombination_Homo sapiens_hsa03440 | 0.92979975 |
| 75 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.92949863 |
| 76 | RNA polymerase_Homo sapiens_hsa03020 | 0.90348755 |
| 77 | Protein export_Homo sapiens_hsa03060 | 0.90191561 |
| 78 | Hepatitis C_Homo sapiens_hsa05160 | 0.90046326 |
| 79 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.89613059 |
| 80 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.89325301 |
| 81 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.88890426 |
| 82 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.88434193 |
| 83 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.86357907 |
| 84 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.86327604 |
| 85 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.86007147 |
| 86 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.82233324 |
| 87 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.80792756 |
| 88 | ABC transporters_Homo sapiens_hsa02010 | 0.80570320 |
| 89 | Alzheimers disease_Homo sapiens_hsa05010 | 0.80549430 |
| 90 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.78918740 |
| 91 | Morphine addiction_Homo sapiens_hsa05032 | 0.78807932 |
| 92 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.78237553 |
| 93 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77723913 |
| 94 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.76730497 |
| 95 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.76637429 |
| 96 | Platelet activation_Homo sapiens_hsa04611 | 0.74292132 |
| 97 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.74188618 |
| 98 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.73389393 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.73179220 |
| 100 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.72980432 |
| 101 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.72980231 |
| 102 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.72206346 |
| 103 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.71045249 |
| 104 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.65006585 |
| 105 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64102012 |
| 106 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.62915443 |
| 107 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.62045018 |
| 108 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.61632641 |
| 109 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.61474293 |
| 110 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.60547354 |
| 111 | Insulin secretion_Homo sapiens_hsa04911 | 0.60364174 |
| 112 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.59782930 |
| 113 | Retinol metabolism_Homo sapiens_hsa00830 | 0.58140423 |
| 114 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.57411660 |
| 115 | Purine metabolism_Homo sapiens_hsa00230 | 0.56472971 |
| 116 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56086510 |
| 117 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.56013941 |
| 118 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.55714410 |
| 119 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.55693641 |
| 120 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55379819 |
| 121 | Tight junction_Homo sapiens_hsa04530 | 0.54205535 |
| 122 | Amoebiasis_Homo sapiens_hsa05146 | 0.53222595 |
| 123 | Circadian entrainment_Homo sapiens_hsa04713 | 0.52744114 |
| 124 | Measles_Homo sapiens_hsa05162 | 0.52244490 |
| 125 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.51782663 |
| 126 | GABAergic synapse_Homo sapiens_hsa04727 | 0.51000536 |
| 127 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.50388553 |
| 128 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.48368260 |
| 129 | Cocaine addiction_Homo sapiens_hsa05030 | 0.47906158 |
| 130 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.47904327 |
| 131 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.47623251 |
| 132 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.45611814 |
| 133 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.45523426 |
| 134 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.44493968 |
| 135 | Viral myocarditis_Homo sapiens_hsa05416 | 0.43204726 |
| 136 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.43054885 |
| 137 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.42316065 |
| 138 | Long-term depression_Homo sapiens_hsa04730 | 0.41698073 |
| 139 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41592138 |
| 140 | RNA degradation_Homo sapiens_hsa03018 | 0.41191522 |
| 141 | Hepatitis B_Homo sapiens_hsa05161 | 0.41027895 |
| 142 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.40990919 |
| 143 | Renin secretion_Homo sapiens_hsa04924 | 0.40581818 |
| 144 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.40493673 |
| 145 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.40387354 |
| 146 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.39229524 |
| 147 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.39134900 |
| 148 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.39119199 |
| 149 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.38712537 |
| 150 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.38699730 |
| 151 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.38648034 |
| 152 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.38326251 |
| 153 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.36458962 |
| 154 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.36119840 |
| 155 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34188612 |
| 156 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.34081967 |
| 157 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.33682850 |
| 158 | Axon guidance_Homo sapiens_hsa04360 | 0.32016154 |
| 159 | Influenza A_Homo sapiens_hsa05164 | 0.31714673 |
| 160 | Bile secretion_Homo sapiens_hsa04976 | 0.30306282 |
| 161 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.29459784 |
| 162 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.29057162 |
| 163 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.26071937 |

